Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years

Journal of the National Cancer Institute

Volumn 90, Issue 12, 1998, Pages 906-910

  White, Emily ^a,b   Velentgas, Priscilla ^a   Mandelson, Margaret T ^c   Lehman, Constance D ^a,b   Elmore, Joann G ^b,c   Porter, Peggy ^a,b   Yasui, Yutaka ^a,b   Taplin, Stephen H ^b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER SCREENING; DENSITY; DIAGNOSTIC ACCURACY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENSTRUAL CYCLE; PREMENOPAUSE; RISK FACTOR;

EID: 0032540643     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.12.906     Document Type: Article

References (34)

1. White E, Urban N, Taylor V. Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu Rev Public Health 1993;14:605-33.
2. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995;75: 2507-17.
3. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276: 33-8.
4. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992; 147:1459-76.
5. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992; 147:1477-88.
6. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin 1982;32:194-225.
7. Smart CR, Hendrick RE, Rutledge JH 3rd, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials Cancer 1995; 75:1619-26.
8. Ernster VL. Mammography screening for women aged 40 through 49 - a guidelines saga and a clarion call for informed decision making. Am J Public Health 1997;87:1103-6.
9. Chevarley F, White E. Recent trends in breast cancer mortality among white and black US women. Am J Public Health 1997;87: 775-81.
10. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976;121: 545-52.
11. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F. The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 1982;115: 438-43.
12. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15:196-208.
13. Gram IT, Funkhouser E, Tabar L. Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer 1995;71: 647-50.
14. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992;84: 781-5.
15. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992;184:613-7.
16. Fajardo LL, Hillman BJ, Frey C. Correlation between breast parenchymal patterns and mammographers' certainty of diagnosis. Invest Radiol 1988;23:505-8.
17. Gohagen JK, editor. National Institutes of Health Consensus Conference on Breast Cancer Screening for Women Ages 40-49. Monogr Natl Cancer Inst 1997;22:1-156.
18. Breast cancer screening for women ages 40-49. NIH Consensus Statement 1997;Jan. 21-23;15(1).
19. Bjarnason GA. Menstrual cycle chronobiology: is it important in breast cancer screening and therapy? Lancet 1996;347:345-6.
20. Baines CJ, Vidmar M, McKoewn-Eyssen G, Tibshirani R. Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study. Cancer 1997; 80:720-4.
21. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981;104: 23-34.
22. Longacre TA, Bartow SA. A correlative morphologic study of the human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986;10:382-93.
23. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
24. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174:487-90.
25. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW. Hormonal replacement therapy: mammographic manifestations. Radiology 1990;174:199-201.
26. Lava MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
27. Meyer F, Brisson J, Morrison AS, Brown JB. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. J Natl Cancer Inst 1986; 77:617-20.
28. Taplin SH, Mandelson MT, Anderman C, White E, Thompson RS, Timlin D, et al. Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 1997;6:625-31.
29. Kopans DB, D'Orsi CJ, Adler DD, Bassett LW, Brenner RJ, Dodd GD, et al. American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). Jefferson (VA): American College of Radiology, 1993.
30. Ferin M, Jewelwicz R, Warren M. The menstrual cycle: physiology, reproductive disorders, and infertility. New York: Oxford University Press, 1993.
31. Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstet Gynecol 1990;97: 595-602.
32. Graham SJ, Stanchev PL, Lloyd-Smith JO, Bronskill MJ, Plewes DB. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 1995;5:695-701.
33. Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. Oxford: Oxford University Press, 1994.
34. Peer PG, van Dijck JA, Hendriks JH, Holland R, Verbeek AL. Age-dependent growth rate of primary breast cancer. Cancer 1993;71: 3547-51.